Peripheral Artery Occlusive Disease

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Xeltis
XeltisNetherlands - Eindhoven
1 program
Xeltis Peripheral Artery DiseaseN/A1 trial
Active Trials
NCT06951685RecruitingEst. Sep 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
XeltisXeltis Peripheral Artery Disease

Clinical Trials (1)

NCT06951685XeltisXeltis Peripheral Artery Disease

Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study

Start: May 2025Est. completion: Sep 2028
N/ARecruiting

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space